Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia
Authors: Latagliata, Roberto; Breccia, Massimo; Fazi, Paola; Iacobelli, Simona; Martinelli, Giovanni; Di Raimondo, Francesco; Sborgia, Marco; Fabbiano, Francesco; Pirrotta, Maria Teresa; Zaccaria, Alfonso; Amadori, Sergio; Caramatti, Cecilia; Falzetti, Franca; Candoni, Anna; Mattei, Daniele; Morselli, Monica; Alimena, Giuliana; Vignetti, Marco; Baccarani, Michele; Mandelli, Franco
Source: British Journal of Haematology,
Volume 143, Number 5, December 2008
, pp. 681-689(9)
Publisher: Blackwell Publishing